首页> 外国专利> SALT FORMULATION OF GLYCYRRHIZIC COMPOUNDS IN THERMO REVERSIBLE GEL AND TRICHLOROACETIC ACID AS A KERATOLYTIC TOPICALLY APPLIED IN THE GENITAL TRACT IN MALES AND FEMALES WITH LESIONS CAUSED BY HUMAN PAPILLOMA VIRUS INFECTIONS AS WELL AS CANCER THEREIN.

SALT FORMULATION OF GLYCYRRHIZIC COMPOUNDS IN THERMO REVERSIBLE GEL AND TRICHLOROACETIC ACID AS A KERATOLYTIC TOPICALLY APPLIED IN THE GENITAL TRACT IN MALES AND FEMALES WITH LESIONS CAUSED BY HUMAN PAPILLOMA VIRUS INFECTIONS AS WELL AS CANCER THEREIN.

机译:在热可逆性凝胶和硫代乙酸中的糖基化合盐的盐溶形式,在人乳头瘤病毒感染以及由其引起的病变的苹果和雌性的生殖道中普遍应用。

摘要

The present invention refers to a novel formulation of ammonium salts of glycyrrhizic compounds such as glycyrrhizin, glycyrrhizic acid or glycyrrhetinic acid in a thermo reversible gel of the polyoxyethylene-polyoxypropylene-polyoxyethylene type as a vehicle at a 25% concentration, the compound being previously dissolved in propylene glycol as an absorption dissolvent or enhancer, at a compound concentration of from about 10, 20, 100mg/ml and to about 200 mg/ml of the active agent of the ammonium salts of glycyrrhizic acid; the compound includes a preserving agent such as methylparaben at a concentration of 0.1%, once the formulation is finished, the trichloroacetic acid being added at a cocnentration of 0.5 to 5.0% and finally the ph is maintained at a rate of 3-7, preferably at 3-5 due to physiological characteristics at a vaginal level. The invention is useful for the treatment of high and low grade intraepithelial squamous lesions related to Human Papilloma Virus recurrent infect ions of high and low oncogenic risk located at the inner and outer genital area such as cervix and vagina, and vulva, penis, anus, and rectum respectively, as well as cancer present in the aforementioned anatomic al regions in men and women.
机译:本发明涉及一种新的甘草酸化合物如甘草酸,甘草酸或甘草次酸的铵盐在作为载体的聚氧乙烯-聚氧丙烯-聚氧乙烯类型的热可逆凝胶中的制剂,其浓度为25%。在丙二醇中作为吸收剂或增强剂,其甘草酸铵盐的活性剂的化合物浓度为约10、20、100mg / ml至约200mg / ml;该化合物包括浓度为0.1%的防腐剂,如对羟基苯甲酸甲酯,配制完成后,以0.5至5.0%的浓度加入三氯乙酸,最后将ph值维持在3-7,优选由于阴道水平的生理特性,在3-5时服用。本发明可用于治疗与高和低致癌风险的人乳头瘤病毒复发感染有关的高级别和低级别上皮内鳞状病变,所述高和低致癌风险位于内外生殖器区域,例如子宫颈和阴道,以及外阴,阴茎,肛门,男性和女性分别在直肠和直肠以及上述解剖区域中存在的癌症。

著录项

  • 公开/公告号MX351117B

    专利类型

  • 公开/公告日2017-10-03

    原文格式PDF

  • 申请/专利权人 DESARROLLOS VPH S.A. DE C.V.;

    申请/专利号MX20110002098

  • 发明设计人 MARÍA ESTHER DRAGUSTINOVIS RUIZ;

    申请日2011-02-25

  • 分类号A61K9/06;A61K8/362;A61K31/765;A61K36/484;A61P17/12;A61P31/20;

  • 国家 MX

  • 入库时间 2022-08-21 13:37:26

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号